Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1879 1
1911 1
1929 1
1931 2
1933 1
1934 1
1943 1
1945 6
1946 25
1947 37
1948 59
1949 58
1950 125
1951 129
1952 102
1953 107
1954 100
1955 93
1956 101
1957 122
1958 107
1959 115
1960 107
1961 128
1962 131
1963 204
1964 223
1965 262
1966 238
1967 213
1968 249
1969 272
1970 295
1971 264
1972 321
1973 354
1974 373
1975 382
1976 419
1977 473
1978 512
1979 475
1980 520
1981 517
1982 589
1983 609
1984 672
1985 621
1986 669
1987 768
1988 718
1989 782
1990 723
1991 764
1992 786
1993 805
1994 960
1995 1005
1996 1072
1997 1169
1998 1315
1999 1512
2000 1641
2001 1660
2002 1667
2003 1839
2004 2017
2005 2261
2006 2402
2007 2645
2008 2901
2009 3082
2010 3468
2011 3921
2012 4220
2013 4757
2014 5063
2015 5250
2016 5436
2017 5489
2018 5635
2019 6042
2020 6811
2021 5671
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

97,582 results
Results by year
Filters applied: . Clear all
Page 1
Classification, diagnosis, and differential diagnosis of multiple sclerosis.
Katz Sand I. Katz Sand I. Curr Opin Neurol. 2015 Jun;28(3):193-205. doi: 10.1097/WCO.0000000000000206. Curr Opin Neurol. 2015. PMID: 25887774 Review.
This review will discuss the classification, diagnosis, and differential diagnosis of multiple sclerosis. RECENT FINDINGS: An international panel of multiple sclerosis experts, the MS Phenotype Group, recently revised the multiple sclerosis
This review will discuss the classification, diagnosis, and differential diagnosis of multiple sclerosis. RECENT FINDINGS: An …
Epidemiology of Multiple Sclerosis.
Howard J, Trevick S, Younger DS. Howard J, et al. Neurol Clin. 2016 Nov;34(4):919-939. doi: 10.1016/j.ncl.2016.06.016. Epub 2016 Aug 18. Neurol Clin. 2016. PMID: 27720001 Review.
The epidemiology of multiple sclerosis (MS) includes a consideration of genetic and environmental factors. ...
The epidemiology of multiple sclerosis (MS) includes a consideration of genetic and environmental factors. ...
Progressive multiple sclerosis: from pathogenic mechanisms to treatment.
Correale J, Gaitán MI, Ysrraelit MC, Fiol MP. Correale J, et al. Brain. 2017 Mar 1;140(3):527-546. doi: 10.1093/brain/aww258. Brain. 2017. PMID: 27794524 Review.
In contrast, current therapeutic options for progressive multiple sclerosis remain comparatively disappointing and challenging. ...This review discusses mechanisms involved in progressive multiple sclerosis, correlations between histopathology and magn …
In contrast, current therapeutic options for progressive multiple sclerosis remain comparatively disappointing and challenging …
Multiple sclerosis.
Nicholas R, Rashid W. Nicholas R, et al. Am Fam Physician. 2013 May 15;87(10):712-4. Am Fam Physician. 2013. PMID: 23939450 Free article. Review. No abstract available.
Multiple sclerosis: clinical aspects.
Oh J, Vidal-Jordana A, Montalban X. Oh J, et al. Curr Opin Neurol. 2018 Dec;31(6):752-759. doi: 10.1097/WCO.0000000000000622. Curr Opin Neurol. 2018. PMID: 30300239 Review.
RECENT FINDINGS: Multiple sclerosis is increasing in incidence and prevalence globally, even in traditionally low-prevalence regions of the world. ...SUMMARY: A number of recent advances have been made in the clinical diagnosis and prognostication of multiple
RECENT FINDINGS: Multiple sclerosis is increasing in incidence and prevalence globally, even in traditionally low-prevalence r …
Multiple sclerosis, a treatable disease.
Doshi A, Chataway J. Doshi A, et al. Clin Med (Lond). 2016 Dec;16(Suppl 6):s53-s59. doi: 10.7861/clinmedicine.16-6-s53. Clin Med (Lond). 2016. PMID: 27956442 Free PMC article. Review.
This article reviews our current understanding and modern treatment of multiple sclerosis (MS). MS is a disabling condition resulting in devastating social and economic impacts. ...
This article reviews our current understanding and modern treatment of multiple sclerosis (MS). MS is a disabling condition re …
Multiple Sclerosis.
Yamout BI, Alroughani R. Yamout BI, et al. Semin Neurol. 2018 Apr;38(2):212-225. doi: 10.1055/s-0038-1649502. Epub 2018 May 23. Semin Neurol. 2018. PMID: 29791948 Free article. Review.
Multiple sclerosis (MS) is a chronic central nervous system inflammatory disease of autoimmune etiology, mediated by activated T cells with evolving evidence of a significant contribution from B cells and cells of the innate immune system. ...
Multiple sclerosis (MS) is a chronic central nervous system inflammatory disease of autoimmune etiology, mediated by activated
Multiple sclerosis.
Wei FC. Wei FC. Biomed J. 2014 Mar-Apr;37(2):33. doi: 10.4103/2319-4170.130317. Biomed J. 2014. PMID: 24732656 Free article. No abstract available.
An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis.
Garg N, Smith TW. Garg N, et al. Brain Behav. 2015 Sep;5(9):e00362. doi: 10.1002/brb3.362. Epub 2015 Aug 3. Brain Behav. 2015. PMID: 26445701 Free PMC article. Review.
BACKGROUND: Multiple sclerosis is an acquired demyelinating disease of the central nervous system. ...
BACKGROUND: Multiple sclerosis is an acquired demyelinating disease of the central nervous system. ...
Highly active multiple sclerosis: An update.
Díaz C, Zarco LA, Rivera DM. Díaz C, et al. Mult Scler Relat Disord. 2019 May;30:215-224. doi: 10.1016/j.msard.2019.01.039. Epub 2019 Jan 24. Mult Scler Relat Disord. 2019. PMID: 30822617 Review.
Multiple sclerosis (MS) is the most prevalent chronic inflammatory disease of the central nervous system (CNS), affecting more than 2 million people worldwide. ...
Multiple sclerosis (MS) is the most prevalent chronic inflammatory disease of the central nervous system (CNS), affecting more
97,582 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page